Business Context and Reporting Period
VisionWave Holdings, Inc. (VWAV) filed a Form 8-K on August 25, 2025, reporting the entry into a Material Definitive Agreement. The Company, an emerging growth company incorporated in Delaware, announced the formation of a strategic joint venture limited liability company (JV LLC) in Nevada with AIPHEX LTD, GBT Tokenize Corp., and GBT Technologies, Inc. The venture focuses on designated defense and technology projects, with specific project details redacted due to confidentiality.
Key Financial Metrics and Capital Structure
This filing does not contain standard financial statements, revenue, profit, cash flow, or debt metrics. The document outlines the following capital and equity allocation details for the new JV LLC:
- Estimated Internal Value: $5,000,000,000 (used solely for equity allocation; not a formal valuation of AIPHEX).
- Ownership Structure:
- VisionWave Holdings, Inc.: 46.76%
- AIPHEX LTD: 46.76%
- GBT Tokenize Corp.: 6.08%
- GBT Technologies, Inc.: 0.40%
- Equity Contributions:
- GBT Tokenize Corp. contributes 897,102 shares of VisionWave common stock and its IP portfolio.
- GBT Technologies, Inc. contributes 2,020,500 shares of VisionWave common stock.
- AIPHEX contributes Designated Projects and Background IP.
- Referral Fee: 700,000 shares of VisionWave common stock (assigned from contributed shares, not newly issued) plus 2% of future JV LLC revenue.
Material Changes and Strategic Developments
The primary material change is the establishment of the JV LLC to serve as the exclusive vehicle for marketing, manufacturing, and managing defense and technology projects. Key structural changes include:
- Board Appointments: Reciprocal rights for VisionWave and AIPHEX to appoint one individual to each other's board of directors. Dr. Moshik Cohen is appointed to VisionWave's advisory board (with potential board appointment and 2,000,000 share options) and Noam Kenig to AIPHEX's advisory board.
- Intellectual Property: New IP developed by the JV LLC will be owned by the entity. Existing IP is licensed non-exclusively to the JV for specific projects.
- Term and Termination: The agreement has a seven-year term. It includes a termination provision where the agreement becomes void and considerations are returned if no revenue is generated from the projects within 12 months of the JV LLC's establishment.
Guidance, Risks, and Contingencies
The filing does not provide financial guidance or revenue forecasts. Management commentary highlights the following risks and contingencies:
- Regulatory Approvals: Transactions are subject to customary closing conditions, including CFIUS clearance, export control licenses, and other governmental consents.
- Confidentiality: Specific details regarding the "Designated Projects" are confidential and redacted from the public filing.
- Operational Risk: The agreement is contingent on generating revenue within 12 months to avoid automatic termination and return of consideration.
Investor Verification Checklist
- Verify the status of required regulatory approvals, specifically CFIUS clearance and export control licenses.
- Confirm the execution of the JV LLC operating agreement, which is required within 30 days of the effective date.
- Monitor the 12-month revenue generation milestone to assess the risk of agreement termination.
- Review the full text of the Strategic Joint Venture Agreement (Exhibit 10.1) for redacted details on the specific defense projects.
- Track the appointment of Dr. Moshik Cohen to the Board of Directors and the issuance of his stock options.